Loading…
Silence Therapeutics plc is projected to rise to $11.27 by 2027, a +14% move from its current price of $9.86. SLN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $9.41 | $9.86 | $10.33 | -0.03% |
| Jul 14 | $9.23 | $9.85 | $10.52 | -0.07% |
| Jul 15 | $9.09 | $9.85 | $10.68 | -0.10% |
| Jul 16 | $8.97 | $9.85 | $10.81 | -0.13% |
| Jul 17 | $8.87 | $9.84 | $10.92 | -0.17% |
| Jul 18 | $8.78 | $9.84 | $11.03 | -0.20% |
| Jul 19 | $8.70 | $9.84 | $11.13 | -0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.70 | $9.84 | $11.13 | -0.23% |
| Week 2 | $8.25 | $9.81 | $11.68 | -0.46% |
| Week 3 | $7.91 | $9.79 | $12.12 | -0.69% |
| Week 4 | $7.64 | $9.77 | $12.50 | -0.92% |
| Week 5 | $7.40 | $9.75 | $12.84 | -1.15% |
| Week 6 | $7.19 | $9.72 | $13.15 | -1.38% |
| Week 7 | $7.00 | $9.70 | $13.44 | -1.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity.
The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.
Silence Therapeutics plc (SLN) is a biotechnology company listed with a current price of $9.95. It has a market capitalization of $469.98M and is ranked 3092 in the market. The stock trades in a context where its price outlook is guided by a multi-year forecast that shows meaningful upside potential, with notable long-run average prices and returns.
A major floor 62.4% below — a decisive break under it would weaken the trend.
The nearest floor, 39.1% below — buyers have tended to step in here.
The nearest ceiling, 11.4% above — a clean break opens room to run.
A major ceiling 38.6% above — clearing it would confirm fresh momentum.
Key SLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.93 | Sell | $9.75 | Buy |
| MA 10 | $10.24 | Sell | $9.70 | Buy |
| MA 20 | $8.86 | Buy | $9.08 | Buy |
| MA 50 | $7.55 | Buy | $7.96 | Buy |
| MA 100 | $6.86 | Buy | $7.22 | Buy |
| MA 200 | $6.42 | Buy | $6.80 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.88 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 10.11 | Neutral |
| Williams %R (14) | -50.94 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | 25.03 | Buy |
| Bollinger %B (20,2) | 0.54 | Neutral |
| Stochastic %K (14) | 49.06 | Neutral |
| TRIX (15) | 1.71 | Buy |
| Awesome (5,34) | 2.05 | Buy |
| Ultimate (7,14,28) | 32.24 | Neutral |
| Momentum (10) | -0.91 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 9.53 | Buy |
| ADX (14) | 27.34 | Buy |
| ATR (14) | 0.37 | Info |
The 30-day technical picture is bullish, with RSI14 at 60 supporting positive momentum. The near-term moving averages show the stock trading above the 50-day average, with SMA50 at $7.48 and SMA200 at $6.37 helping define the trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.30 | $9.86 | $11.81 | 0% | Neutral | |
| $8.39 | $11.27 | $16.32 | +14% | Neutral | |
| $10.34 | $14.64 | $22.44 | +48% | Bullish | |
| $12.12 | $17.91 | $28.69 | +82% | Bullish | |
| $14.45 | $22.21 | $36.91 | +125% | Bullish | |
| $13.67 | $21.79 | $37.36 | +121% | Bullish | |
| $13.70 | $22.61 | $39.87 | +129% | Bullish | |
| $15.15 | $25.84 | $46.73 | +162% | Bullish | |
| $13.33 | $23.47 | $43.43 | +138% | Bullish | |
| $17.01 | $30.88 | $58.37 | +213% | Bullish | |
| $20.77 | $43.70 | $90.11 | +343% | Bullish | |
| $48.40 | $107.56 | $247.39 | +991% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.30 | $9.86 | $11.82 | +0.00% |
| August 2026 | $7.74 | $9.32 | $11.64 | -5.52% |
| September 2026 | $7.85 | $9.57 | $12.17 | +2.70% |
| October 2026 | $7.93 | $9.76 | $12.60 | +1.98% |
| November 2026 | $7.39 | $9.17 | $12.00 | -5.97% |
| December 2026 | $7.12 | $8.92 | $11.81 | -2.76% |
Click any year to see its month-by-month SLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SLN could reach as high as $11.81, with a base case around $9.86 and support toward $4.30 — roughly 0% from $9.86. Price action looks broadly range-bound.
Expect SLN to range from $8.39 to $16.32 through 2027. The $11.27 average target implies a +14% move from current prices. That is up +14% on the projected 2026 average. A consolidation phase looks the most probable path here.
The SLN price prediction for 2028 points to an average of $14.64 (low $10.34, high $22.44) — a potential gain of +48% on today's $9.86. Momentum favours further upside here.
In 2029, SLN is projected to trade between $12.12 and $28.69, averaging $17.91 — a potential gain of +82% from today's $9.86. That is up +22% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Silence Therapeutics plc's 2030 outlook centres on $22.21, within a $14.45 to $36.91 range. That is up +24% on the projected 2029 average. That marks a +125% change versus current levels. Momentum favours further upside here.
By 2031, SLN could reach as high as $37.36, with a base case around $21.79 and support toward $13.67 — roughly +121% from $9.86. Buyers look set to stay in control over this stretch.
Expect SLN to range from $13.70 to $39.87 through 2032. The $22.61 average target implies a +129% move from current prices. That is up +4% on the projected 2031 average. Momentum favours further upside here.
The SLN price prediction for 2033 points to an average of $25.84 (low $15.15, high $46.73) — a potential gain of +162% on today's $9.86. Buyers look set to stay in control over this stretch.
In 2034, SLN is projected to trade between $13.33 and $43.43, averaging $23.47 — a potential gain of +138% from today's $9.86. That is -9% versus the projected 2033 average. Momentum favours further upside here.
Silence Therapeutics plc's 2035 outlook centres on $30.88, within a $17.01 to $58.37 range. That is up +32% on the projected 2034 average. That marks a +213% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, SLN could reach as high as $90.11, with a base case around $43.70 and support toward $20.77 — roughly +343% from $9.86. Momentum favours further upside here.
Expect SLN to range from $48.40 to $247.39 through 2050. The $107.56 average target implies a +991% move from current prices. That is up +146% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SLN today (≈ 101.419878 SLN) could be worth
$10,908.99
+$9,908.99 (+991%) by 2050 · US Dollar
Based on the average projected SLN price of $107.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SLNwould be worth at today's price.
$1,000 invested in SLN on Jul 10, 2025 (≈ 155.763238 SLN) would be worth
$1,535.83
+$535.83 (+53.6%) today · 1.54× · US Dollar
Based on a SLN entry price of $6.42 vs. today's $9.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.39 | $948.99 | -5.1% |
| 1 month ago | $6 | $1,643.33 | +64.3% |
| 3 months ago | $5.73 | $1,720.77 | +72.1% |
| 6 months ago | $5.9 | $1,671.19 | +67.1% |
| 1 year ago | $6.42 | $1,535.83 | +53.6% |
| All time (5.0y) ago | $24.06 | $409.81 | -59.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SLN forecast.
Our base-case forecast reaches $20.00 around 2030.
Implied market cap at $20.00: $944.69M
The multi-year forecast remains bullish across the horizon. In 2030, the average price is projected at $26.72 with an upside of 168.5% and a bullish sentiment. By 2040, the average price is forecast at $63.00 with an upside of 533.1% and continued bullish sentiment.
By 2050, the average price is forecast at $168.29 with an upside of 1591.3% and a bullish outlook. These figures imply substantial long-run upside, though they are estimates and not guarantees. The forecasted path is accompanied by high volatility (annualized volatility pct 90), underscoring the risk and variability inherent in longer-horizon projections.
Tap a question to reveal the answer.
2030 forecast: avg $26.72; min $17.41; max $44.33; ROI 168.5; sentiment bullish.
Forecasts show bullish sentiment in multiple years beyond 2026 with positive ROI figures (e.g., 2027 avg $12.41; 2028 avg $17.11; 2029 avg $21.31; 2030 avg $26.72), but these are estimates, not guarantees.
Yes—2032 max is $50.31; 2032 avg is $28.58; min $17.36.
Current price $9.95; market cap $469.98M; rank 3092.
RSI14 60; SMA50 $7.48; SMA200 $6.37; support $6.00; resistance $10.98; 30-day range $7.33-$13.50; sentiment bullish.
Silence Therapeutics plc Community Discussion
0Share your Silence Therapeutics plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.